Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (FY)Dec 30, 2024 | (FY)Dec 30, 2023 | |
|---|---|---|
| Operating cash flow (direct method) | ||
| Cash income from operating activities | 72.94%165.15M | 95.49M |
| Revenue from customers | 72.94%165.15M | --95.49M |
| Cash paid | -42.76%-119.34M | -83.59M |
| Payments to suppliers for goods and services | -42.76%-119.34M | ---83.59M |
| Direct interest paid | -49.16%-17.32M | ---11.61M |
| Operating cash flow | 9,625.26%28.5M | --293K |
| Investing cash flow | ||
| Cash flow from continuing investing activities | 69.45%-24.34M | -79.67M |
| Net PPE purchase and sale | -231.91%-1.17M | ---351K |
| Net business purchase and sale | 84.95%-11.03M | ---73.31M |
| Net other investing changes | -102.35%-12.14M | ---6M |
| Cash from discontinued investing activities | ||
| Investing cash flow | 69.45%-24.34M | ---79.67M |
| Financing cash flow | ||
| Cash flow from continuing financing activities | -125.55%-26.22M | 102.63M |
| Net issuance payments of debt | -235.12%-23M | --17.02M |
| Net common stock issuance | ---- | --99.56M |
| Net other financing activities | 76.92%-3.22M | ---13.96M |
| Cash from discontinued financing activities | ||
| Financing cash flow | -125.55%-26.22M | --102.63M |
| Net cash flow | ||
| Beginning cash position | 1,005.93%25.57M | --2.31M |
| Current changes in cash | -194.87%-22.06M | --23.26M |
| End cash Position | -86.29%3.51M | --25.57M |
| Free cash from | 47,220.69%27.33M | ---58K |
| Accounting Standards | US-GAAP | US-GAAP |